TKM-PLK1 Archives

TGen-Scottsdale Healthcare battle tumor growth

clinical research advantage - vaccines

The safety and preliminary efficacy of a new class of tumor fighting drugs were reported by Scottsdale Healthcare’s Virginia G. Piper Cancer Center Clinical Trials and the Translational Genomics Research Institute (TGen). Early results from the phase I, first in-human study of an RNA interface (RNAi) drug were announced during the American Association for Cancer… Read More →